NCT01214135已完成不适用
A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Inpatients With Schizophrenia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- To investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia
研究概览
简要总结
The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of schizophrenia.
- •At least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 - 30th of September 2010).
- •Hospitalization due to psychotic symptoms at any time during the study period (1st of July 2009 - 30th of September 2010) and with admission and discharge dates available.
排除标准
- •Participation in a clinical trial during the study period.
- •Treatment in forensic care according to LRV ("Lagen om Rättspsykiatrisk Vård").
结局指标
主要结局
To investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia
时间窗: every day for the time period of 15 Oct to 31 Dec 2010
次要结局
- To investigate comorbidities of patients with schizophrenia receiving Seroquel XR and IR(every day for the time period of 15 Oct to 31 Dec 2010)
- To investigate whether Seroquel XR and Seroquel IR are used to treat different types of inpatients with schizophrenia by evaluation of patient characteristics(every day for the time period of 15 Oct to 31 Dec 2010)
- To investigate the treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR(every day for the time period of 15 Oct to 31 Dec 2010)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With SchizophreniaSchizophreniaNCT01212575AstraZeneca186
终止
4 期
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current TherapyAcute Bipolar ManiaNCT01128114AstraZeneca32
终止
4 期
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,StudyAcute Bipolar ManiaNCT01254721AstraZeneca131
已完成
4 期
A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With SchizophreniaSchizophreniaNCT00817648Shanghai Mental Health Center120
已完成
不适用
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate ExtendedSchizophreniaNCT00922090AstraZeneca1,494